ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
69 002,57
-0,38%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Tetraphase Pharmaceuticals Inc (TTPH)

  7. Tetraphase Pharmaceuticals Inc (TTPH) Actualités

TTPH

Tetraphase Pharmaceuticals (TTPH)

Tetraphase Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TTPH
DateHeureSourceTitreSymboleSociété
31/08/202021h20Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
31/08/202012h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
25/08/202012h02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
25/08/202012h01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
11/08/202020h56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
31/07/202012h37Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202023h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202015h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202012h02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202012h01Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
28/07/202022h15GlobeNewswire Inc.La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/06/202015h50Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/06/202015h31Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202014h01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202013h47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202013h30GlobeNewswire Inc.La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.NASDAQ:TTPHTetraphase Pharmaceuticals Inc
22/06/202012h00Business WireTetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer & Notice to Me...NASDAQ:TTPHTetraphase Pharmaceuticals Inc
04/06/202015h22Business WireMelinta Therapeutics to Acquire Tetraphase PharmaceuticalsNASDAQ:TTPHTetraphase Pharmaceuticals Inc
04/06/202000h50PR Newswire (US)AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire TetraphaseNASDAQ:TTPHTetraphase Pharmaceuticals Inc
01/06/202023h12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
01/06/202022h51Business WireTetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRxNASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/05/202014h43Business WireTetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased ConsiderationNASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/05/202014h30PR Newswire (US)AcelRx Pharmaceuticals Announces Revised Merger Agreement with TetraphaseNASDAQ:TTPHTetraphase Pharmaceuticals Inc
27/05/202015h25Business WireTetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased ConsiderationNASDAQ:TTPHTetraphase Pharmaceuticals Inc
22/05/202003h55Business WireTetraphase Announces Determination of Superior Offer and Notice to AcelRxNASDAQ:TTPHTetraphase Pharmaceuticals Inc
07/05/202022h15Business WireTetraphase Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate DevelopmentsNASDAQ:TTPHTetraphase Pharmaceuticals Inc
07/05/202022h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/04/202022h09Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
21/04/202003h56PR Newswire (US)SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?NASDAQ:TTPHTetraphase Pharmaceuticals Inc
18/03/202018h52PR Newswire (US)Moore Kuehn Encourages DLPH, CSFL, TTPH, and FSCT Investors to Contact Law FirmNASDAQ:TTPHTetraphase Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TTPH

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
EU
DG
Vinci
EU
CAP
Capgemini
EU
EN
Bouygues
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
NASDAQ
GOOGL
Alphabet
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
EU
HO
Thales
EU
AI
Air Liquide
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés